FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281762287> ?p ?o ?g. }

• W4281762287 abstract "Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): British Heart Foundation and Propionic Acidemia Foundation Background In the heart, various metabolic pathways produce the three-carbon intermediate, propionate. This metabolite has been postulated to increase histone propionylation and acetylation (via deacetylase inhibition), and therefore affect transcription. Normally, propionate levels are kept low by propionyl-CoA carboxylase (PCC), but build-up has been reported in cardiometabolic diseases. The highest levels are attained in propionic acidaemia (PA; mutations in PCC), which also serves as a model for studying propionate biology [1]. Purpose To establish the effect of propionate on cardiac gene expression and physiology using a mouse model of elevated propionate/propionyl-CoA signalling. Methods Experiments were performed using either wild-type (WT) neonatal ventricular myocytes (NRVMs) treated with propionate in vitro, or the hypomorphic mouse model of PA (Pcca-/- A138T) [2]. IC-MS metabolomics was performed on methanol-extracted metabolites. RNA-sequencing was carried out on an Illumina HiSeq 4000. For chromatin immunoprecipitation (ChIP), chromatin was isolated from PFA-fixed ventricular tissue. cGMP levels were measured by the FRET-based sensor, cGi500. Ca2+ transients were imaged in isolated myocytes using FuraRed. Cine-MRI was performed in a 7 tesla MR scanner. Results PA mice had the metabolic signature of propionate accumulation in plasma and cardiac lysates (metabolomics). RNA-seq of ventricular lysates identified differentially expressed genes (DEGs), but the effect was more pronounced in females. Thus, subsequent experiments were performed in females. To determine which DEGs are likely a direct response to propionate, RNA-seq was performed on propionate-treated NRVMs. The most significant DEGs common to both datasets were upregulated Pde9a (cGMP-selective phosphodiesterase) and Mme (degrades natriuretic peptides). ChIP-qPCR for histone acylation in PA and WT hearts demonstrated increases in H3K27ac at Pde9a, and strikingly, increases in propionylation at Pde9a and Mme, indicating a mechanism for this transcriptional induction. Propionate-treated NRVMs show greater sensitivity of cGMP to pharmacological inhibition of PDE9A (measured by FRET), consistent with Pde9a induction. Such changes are expected to result in diastolic dysfunction [3]. Indeed, ventricular myocytes from PA mice had higher diastolic Ca2+. Cine-MRI confirmed contractile dysfunction in vivo, with PA mice manifesting increased end-systolic and end-diastolic volumes. Conclusions We demonstrate that cardiac elevations of the metabolic intermediate, propionate, increases histone modifications that drive transcriptional changes in the heart, including those involved in cyclic nucleotide signalling. We also present evidence for histone propionylation, which has not been described previously in the heart. Thus, using a mouse model of a rare metabolic disease, we show how propionate/propionyl-CoA signalling affects cardiac function through epigenetic changes." @default.
• W4281762287 created "2022-06-13" @default.
• W4281762287 creator A5002651476 @default.
• W4281762287 creator A5006418746 @default.
• W4281762287 creator A5026204246 @default.
• W4281762287 creator A5031245472 @default.
• W4281762287 creator A5043602547 @default.
• W4281762287 creator A5047494090 @default.
• W4281762287 creator A5050351989 @default.
• W4281762287 creator A5052029669 @default.
• W4281762287 creator A5052117455 @default.
• W4281762287 creator A5065608754 @default.
• W4281762287 creator A5074911713 @default.
• W4281762287 creator A5075540122 @default.
• W4281762287 creator A5091164197 @default.
• W4281762287 date "2022-06-01" @default.
• W4281762287 modified "2023-10-15" @default.
• W4281762287 title "Elevated propionate signalling drives Pde9a overexpression and contractile dysfunction through increased histone acetylation and propionylation" @default.
• W4281762287 doi "https://doi.org/10.1093/cvr/cvac066.035" @default.
• W4281762287 hasPublicationYear "2022" @default.
• W4281762287 type Work @default.
• W4281762287 citedByCount "0" @default.
• W4281762287 crossrefType "journal-article" @default.
• W4281762287 hasAuthorship W4281762287A5002651476 @default.
• W4281762287 hasAuthorship W4281762287A5006418746 @default.
• W4281762287 hasAuthorship W4281762287A5026204246 @default.
• W4281762287 hasAuthorship W4281762287A5031245472 @default.
• W4281762287 hasAuthorship W4281762287A5043602547 @default.
• W4281762287 hasAuthorship W4281762287A5047494090 @default.
• W4281762287 hasAuthorship W4281762287A5050351989 @default.
• W4281762287 hasAuthorship W4281762287A5052029669 @default.
• W4281762287 hasAuthorship W4281762287A5052117455 @default.
• W4281762287 hasAuthorship W4281762287A5065608754 @default.
• W4281762287 hasAuthorship W4281762287A5074911713 @default.
• W4281762287 hasAuthorship W4281762287A5075540122 @default.
• W4281762287 hasAuthorship W4281762287A5091164197 @default.
• W4281762287 hasBestOaLocation W42817622871 @default.
• W4281762287 hasConcept C101762097 @default.
• W4281762287 hasConcept C104317684 @default.
• W4281762287 hasConcept C134320426 @default.
• W4281762287 hasConcept C150194340 @default.
• W4281762287 hasConcept C2776202225 @default.
• W4281762287 hasConcept C2778305200 @default.
• W4281762287 hasConcept C2780014933 @default.
• W4281762287 hasConcept C55493867 @default.
• W4281762287 hasConcept C64927066 @default.
• W4281762287 hasConcept C86803240 @default.
• W4281762287 hasConcept C95444343 @default.
• W4281762287 hasConceptScore W4281762287C101762097 @default.
• W4281762287 hasConceptScore W4281762287C104317684 @default.
• W4281762287 hasConceptScore W4281762287C134320426 @default.
• W4281762287 hasConceptScore W4281762287C150194340 @default.
• W4281762287 hasConceptScore W4281762287C2776202225 @default.
• W4281762287 hasConceptScore W4281762287C2778305200 @default.
• W4281762287 hasConceptScore W4281762287C2780014933 @default.
• W4281762287 hasConceptScore W4281762287C55493867 @default.
• W4281762287 hasConceptScore W4281762287C64927066 @default.
• W4281762287 hasConceptScore W4281762287C86803240 @default.
• W4281762287 hasConceptScore W4281762287C95444343 @default.
• W4281762287 hasIssue "Supplement_1" @default.
• W4281762287 hasLocation W42817622871 @default.
• W4281762287 hasOpenAccess W4281762287 @default.
• W4281762287 hasPrimaryLocation W42817622871 @default.
• W4281762287 hasRelatedWork W1721461233 @default.
• W4281762287 hasRelatedWork W1982071355 @default.
• W4281762287 hasRelatedWork W2027591587 @default.
• W4281762287 hasRelatedWork W2088468764 @default.
• W4281762287 hasRelatedWork W2123257716 @default.
• W4281762287 hasRelatedWork W2953927403 @default.
• W4281762287 hasRelatedWork W3088117346 @default.
• W4281762287 hasRelatedWork W3138965082 @default.
• W4281762287 hasRelatedWork W4250705761 @default.
• W4281762287 hasRelatedWork W4281762287 @default.
• W4281762287 hasVolume "118" @default.
• W4281762287 isParatext "false" @default.
• W4281762287 isRetracted "false" @default.
• W4281762287 workType "article" @default.